Skip to main content
icon for Weed rescheduled by...?

Weed rescheduled by...?

icon for Weed rescheduled by...?

Weed rescheduled by...?

Mar 31

Mar 31

$758,306 Vol.

Mar 31, 2026
Polymarket

$758,306 Vol.

Polymarket

June 30

$336,932 Vol.

2%

December 31

$156,491 Vol.

25%

This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by March 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.On April 23, 2026, the Trump administration's Department of Justice, via Acting Attorney General Todd Blanche, issued a final order rescheduling FDA-approved marijuana products and state-licensed medical cannabis from Schedule I to Schedule III of the Controlled Substances Act, providing tax relief under Section 280E and easing research barriers while leaving recreational marijuana in Schedule I. This partial reform followed the prior HHS scientific recommendation but terminated earlier proceedings, prompting a new DEA administrative hearing starting June 29, 2026, to evaluate broader rescheduling amid legal challenges and a congressional committee vote to block full changes. Traders weigh the hearing's timeline, potential delays in rulemaking, and political pressures as key factors for near-term resolution.

This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.
Volume
$758,306
Petsa ng Pagtatapos
Mar 31, 2026
Binuksan ang Market
Feb 7, 2026, 5:04 PM ET
This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.
This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by March 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.On April 23, 2026, the Trump administration's Department of Justice, via Acting Attorney General Todd Blanche, issued a final order rescheduling FDA-approved marijuana products and state-licensed medical cannabis from Schedule I to Schedule III of the Controlled Substances Act, providing tax relief under Section 280E and easing research barriers while leaving recreational marijuana in Schedule I. This partial reform followed the prior HHS scientific recommendation but terminated earlier proceedings, prompting a new DEA administrative hearing starting June 29, 2026, to evaluate broader rescheduling amid legal challenges and a congressional committee vote to block full changes. Traders weigh the hearing's timeline, potential delays in rulemaking, and political pressures as key factors for near-term resolution.

This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.
Volume
$758,306
Petsa ng Pagtatapos
Mar 31, 2026
Binuksan ang Market
Feb 7, 2026, 5:04 PM ET
This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.

Mag-ingat sa mga external link.

Mga Madalas na Tanong

Ang "Weed rescheduled by...?" ay isang prediction market sa Polymarket na may 3 posibleng outcomes kung saan bumibili at nagbebenta ang mga trader ng shares batay sa kanilang pinaniniwalaan na mangyayari. Ang kasalukuyang nangunguna ay " December 31" sa 25%, sinusundan ng "June 30" sa 2%. Ang mga presyo ay sumasalamin sa real-time crowd-sourced probabilities. Halimbawa, ang isang share na naka-presyo sa 25¢ ay nagpapahiwatig na kolektibong itinatakda ng market ang 25% na tsansa sa outcome na iyon. Patuloy na nagbabago ang mga odds na ito habang tumutugon ang mga trader sa mga bagong development at impormasyon. Ang mga shares sa tamang outcome ay mare-redeem sa $1 bawat isa sa market resolution.

Sa ngayon, ang "Weed rescheduled by...?" ay naka-generate ng $758.3K sa kabuuang trading volume mula nang ilunsad ang market noong Nov 5, 2025. Ang antas na ito ng trading activity ay sumasalamin sa malakas na engagement mula sa Polymarket community at tumutulong na matiyak na ang kasalukuyang odds ay sinusuportahan ng malawak na pool ng mga market participant. Maaari mong subaybayan ang live price movements at mag-trade sa anumang outcome nang direkta sa pahinang ito.

Para mag-trade sa "Weed rescheduled by...?," i-browse ang 3 available na outcomes na nakalista sa pahinang ito. Ang bawat outcome ay may kasalukuyang presyo na kumakatawan sa implied probability ng market. Para kumuha ng posisyon, piliin ang outcome na pinaniniwalaan mong pinaka-malamang, piliin ang "Yes" para mag-trade pabor dito o "No" para mag-trade laban dito, ilagay ang iyong halaga, at i-click ang "Trade." Kung tama ang iyong napiling outcome kapag na-resolve ang market, nagbabayad ang iyong "Yes" shares ng $1 bawat isa. Kung mali, nagbabayad ang mga ito ng $0. Maaari ka ring magbenta ng iyong shares anumang oras bago ang resolution kung gusto mong i-lock in ang kita o bawasan ang pagkalugi.

Ang kasalukuyang frontrunner para sa "Weed rescheduled by...?" ay " December 31" sa 25%, ibig sabihin itinatakda ng market ang 25% na tsansa sa outcome na iyon. Ang sumunod na pinaka-malapit na outcome ay "June 30" sa 2%. Nag-a-update ang mga odds na ito sa real-time habang bumibili at nagbebenta ang mga trader ng shares, kaya sinasalamin nila ang pinakabagong kolektibong view kung ano ang pinaka-malamang na mangyari. Bumalik nang madalas o i-bookmark ang pahinang ito para sundan kung paano nagbabago ang odds habang lumilitaw ang bagong impormasyon.

Ang mga resolution rules para sa "Weed rescheduled by...?" ay tiyak na nagde-define kung ano ang kailangang mangyari para sa bawat outcome na maideklara bilang panalo — kasama ang mga opisyal na data source na ginagamit para matukoy ang resulta. Maaari mong i-review ang kumpletong resolution criteria sa "Rules" section sa pahinang ito sa itaas ng mga komento. Inirerekomenda namin na basahin nang mabuti ang mga patakaran bago mag-trade, dahil tinutukoy nila ang mga tiyak na kondisyon, edge cases, at mga source na namamahala kung paano nise-settle ang market na ito.